Possible association of trichorhinophalangeal syndrome I and intracranial subependymoma
Clinical Genetics · 2023
DOI: 10.1111/cge.14299 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Genetics, 2023. Verfasst von Donald A Ross und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, Oregon Health & Science University, Portland, Oregon, USA. Hauptthemen laut MEDLINE: Langer-Giedion Syndrome, Glioma, Subependymal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurological Surgery, Oregon Health & Science University, Portland, Oregon, USA.
- Operative Care Division, Portland Veterans Administration Medical Center, Portland, Oregon, USA.
- Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
- Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway.
- Department of Radiology, Oregon Health & Science University, Portland, Oregon, USA.
Zitieren
APA
Ross, D. A., Berland, S., Helland, C. A., & Pettersson, D. R. (2023). Possible association of trichorhinophalangeal syndrome I and intracranial subependymoma. Clinical Genetics. https://doi.org/10.1111/cge.14299
Vancouver
Ross DA, Berland S, Helland CA, Pettersson DR. Possible association of trichorhinophalangeal syndrome I and intracranial subependymoma. Clinical Genetics. 2023. doi:10.1111/cge.14299
BibTeX
@article{Ross2023,
author = {Ross, Donald A and Berland, Siren and Helland, Christian A and Pettersson, David R},
title = {Possible association of trichorhinophalangeal syndrome I and intracranial subependymoma},
journal = {Clinical Genetics},
year = {2023},
doi = {10.1111/cge.14299}
}
EUVIMED